Impact of the first-generation drug-eluting stent implantation on periprocedural myocardial injury in patients with stable angina pectoris

Journal of Cardiology

Volumn 60, Issue 4, 2012, Pages 264-269

  Okada, Takuya ^a   Yoshikawa, Daiji ^b   Ishii, Hideki ^b   Matsumoto, Masaya ^b   Hayakawa, Seiichi ^b   Matsudaira, Kyoko ^b   Tanaka, Miho ^b   Kumagai, Soichiro ^b   Hayashi, Mutsuharu ^b   Ando, Hirohiko ^c   Amano, Tetsuya ^d   Murohara, Toyoaki ^b  

^a CHUKYO HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c CHUBU ROSAI HOSPITAL   (Japan)

^d AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Coronary artery disease; Myocardial infarction; Stent

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; BLOOD CLOT LYSIS; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; HEART MUSCLE INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE COMPLICATION; PERIPROCEDURAL MYOCARDIAL INJURY; STABLE ANGINA PECTORIS;

AGED; ANGINA, STABLE; BIOLOGICAL MARKERS; CREATINE KINASE, MB FORM; DRUG-ELUTING STENTS; FEMALE; HEART INJURIES; HUMANS; LOGISTIC MODELS; MALE; METALS; PACLITAXEL; SIROLIMUS; STENTS;

EID: 84866545171     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2012.05.008     Document Type: Article

References (36)

1. Assali A.R., Moustapha A., Sdringola S., Denktas A.E., Willerson J.T., Holmes D.R., Smalling R.W. Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (the PRESTO trial). Am J Cardiol 2006, 98:729-733.
2. Schühlen H., Kastrati A., Mehilli J., Hausleiter J., Pache J., Dirschinger J., Schömig A. Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement. Am Heart J 2004, 147:317-322.
3. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., Jaeger J.L., Kuntz R.E. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003, 349:1315-1323. SIRIUS Investigators.
4. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., Popma J.J., Russell M.E. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004, 350:221-231. TAXUS-IV Investigators.
5. Yoshikawa D., Isobe S., Umeda H., Kawai T., Shimizu T., Yamashita K., Ishii H., Murohara T. Three-year prognosis of Japanese patients with ST-elevation myocardial infarction treated with sirolimus-eluting stents. Coron Artery Dis 2009, 20:422-427.
6. Kastrati A., Mehilli J., Pache J., Kaiser C., Valgimigli M., Kelbaek H., Menichelli M., Sabaté M., Suttorp M.J., Baumgart D., Seyfarth M., Pfisterer M.E., Schömig A. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007, 356:1030-1039.
7. Katritsis D.G., Karvouni E., Ioannidis J.P. Meta-analysis comparing drug-eluting stents with bare metal stents. Am J Cardiol 2005, 95:640-643.
8. Simsek C., Magro M., Boersma E., Onuma Y., Nauta S.T., Gaspersz M.P., van der Giessen W.J., van Domburg R.T., Serruys P.W. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries. JACC Cardiovasc Interv 2010, 3:1051-1058. Interventional Cardiologists of the Thoraxcenter.
9. Kong T.Q., Davidson C.J., Meyers S.N., Tauke J.T., Parker M.A., Bonow R.O. Prognostic implication of creatine kinase elevation following elective coronary artery interventions. JAMA 1997, 277:461-466.
10. Kini A.S., Lee P., Marmur J.D., Agarwal A., Duffy M.E., Kim M.C., Sharma S.K. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality. Am J Cardiol 2004, 93:18-23.
11. Ioannidis J.P., Karvouni E., Katritsis D.G. Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention. J Am Coll Cardiol 2003, 42:1406-1411.
12. Akkerhuis K.M., Alexander J.H., Tardiff B.E., Boersma E., Harrington R.A., Lincoff A.M., Simoons M.L. Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different?. Circulation 2002, 105:554-556.
13. The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. New Engl J Med 1985, 312:932-936. TIMI Study Group.
14. Ryan T.J., Bauman W.B., Kennedy J.W., Kereiakes D.J., King S.B., McCallister B.D., Smith S.C., Ullyot D.J. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1993, 88:2987-3007.
15. Alpert J.S., Thygesen K., Antman E., Bassand J.P. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000, 36:959-969.
16. Hanna E.B., Hennebry T.A. Periprocedural myocardial infarction: review and classification. Clin Cardiol 2010, 33:476-483.
17. Jensen L.O., Maeng M., Kaltoft A., Thayssen P., Hansen H.H., Bottcher M., Lassen J.F., Krussel L.R., Rasmussen K., Hansen K.N., Pedersen L., Johnsen S.P., Soerensen H.T., Thuesen L. Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions. J Am Coll Cardiol 2007, 50:463-470.
18. Nakazawa G. Stent thrombosis of drug eluting stent: pathological perspective. J Cardiol 2011, 58:84-91.
19. Takayama T., Hiro T., Hirayama A. Stent thrombosis and drug-eluting stents. J Cardiol 2011, 58:92-98.
20. Nishihira K., Hatakeyama K., Kuriyama N., Nomura K., Fukushima Y., Inoue Y., Nakama T., Mine D., Sagara S., Ashikaga K., Matsuyama A., Kitamura K., Shibata Y., Asada Y. Presence of older thrombus in patients with late and very late drug-eluting stent thrombosis. J Cardiol 2012, 59:57-63.
21. Herrmann J. Peri-procedural myocardial injury: 2005 update. Eur Heart J 2005, 26:2493-2519.
22. Hoole S.P., Heck P.M., Sharples L., Dutka D.P., West N.E. Coronary stent length predicts PCI-induced cardiac myonecrosis. Coron Artery Dis 2010, 21:312-317.
23. Babu G.G., Walker J.M., Yellon D.M., Hausenloy D.J. Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection. Eur Heart J 2011, 32:23-31.
24. Li J., Jabara R., Pendyala L., Otsuka Y., Shinke T., Hou D., Robinson K., Chronos N. Abnormal vasomotor function of porcine coronary arteries distal to sirolimus-eluting stents. JACC Cardiovasc Interv 2008, 1:279-285.
25. Pendyala L.K., Li J., Shinke T., Geva S., Yin X., Chen J.P., King S.B., Robinson K.A., Chronos N.A., Hou D. Endothelium-dependent vasomotor dysfunction in pig coronary arteries with paclitaxel-eluting stents is associated with inflammation and oxidative stress. JACC Cardiovasc Interv 2009, 2:253-262.
26. Kim J.W., Suh S.Y., Choi C.U., Na J.O., Kim E.J., Rha S.W., Park C.G., Seo H.S., Oh D.J. Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus paclitaxel-eluting stent. JACC Cardiovasc Interv 2008, 1:65-71.
27. Hofma S.H., van der Giessen W.J., van Dalen B.M., Lemos P.A., McFadden E.P., Sianos G., Ligthart J.M., van Essen D., de Feyter P.J., Serruys P.W. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J 2006, 27:166-170.
28. Obata J.E., Nakamura T., Kitta Y., Kodama Y., Sano K., Kawabata K., Saitoh Y., Fujioka D., Kobayashi T., Yano T., Watanabe Y., Watanabe K., Kugiyama K. Treatment of acute myocardial infarction with sirolimus-eluting stents results in chronic endothelial dysfunction in the infarct-related coronary artery. Circ Cardiovasc Interv 2009, 2:384-391.
29. Kim J.W., Park C.G., Seo H.S., Oh D.J. Delayed severe multivessel spasm and aborted sudden death after Taxus stent implantation. Heart 2005, 91:e15.
30. Wheatcroft S., Byrne J., Thomas M., MacCarthy P. Life-threatening coronary artery spasm following sirolimus-eluting stent deployment. J Am Coll Cardiol 2006, 47:1911-1912.
31. Maekawa K., Kawamoto K., Fuke S., Yoshioka R., Saito H., Sato T., Hioka T. Severe endothelial dysfunction after sirolimus-eluting stent implantation. Circulation 2006, 113:e850-e851.
32. Hamasaki S., Tei C. Effect of coronary endothelial function on outcomes in patients undergoing percutaneous coronary intervention. J Cardiol 2011, 57:231-238.
33. Pasceri V., Patti G., Nusca A., Pristipino C., Richichi G., Di Sciascio G. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Circulation 2004, 110:674-678. ARMYDA Investigators.
34. Briguori C., Colombo A., Airoldi F., Violante A., Focaccio A., Balestrieri P., Paolo Elia P., Golia B., Lepore S., Riviezzo G., Scarpato P., Librera M., Bonizzoni E., Ricciardelli B. Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction. Eur Heart J 2004, 25:1822-1828.
35. Miyagi M., Ishii H., Murakami R., Isobe S., Hayashi M., Amano T., Arai K., Ohashi T., Uetani T., Matsubara T., Murohara T. Impact of long-term statin treatment on coronary plaque composition at angiographically severe lesions: a nonrandomized study of the history of long-term statin treatment before coronary angioplasty. Clin Ther 2009, 31:64-73.
36. Steinhubl S.R., Lauer M.S., Mukherjee D.P., Moliterno D.J., Lincoff A.M., Ellis S.G., Topol E.J. The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non-Q-wave myocardial infarctions. J Am Coll Cardiol 1998, 32:1366-1370.